These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25535979)
1. Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas. He W; Liu R; Yang SH; Yuan F Anticancer Drugs; 2015 Mar; 26(3):293-300. PubMed ID: 25535979 [TBL] [Abstract][Full Text] [Related]
2. Differential Characterization of Temozolomide-Resistant Human Glioma Cells. Lai SW; Huang BR; Liu YS; Lin HY; Chen CC; Tsai CF; Lu DY; Lin C Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301329 [TBL] [Abstract][Full Text] [Related]
3. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells. Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778 [TBL] [Abstract][Full Text] [Related]
4. Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics. St-Coeur PD; Poitras JJ; Cuperlovic-Culf M; Touaibia M; Morin P J Neurooncol; 2015 Oct; 125(1):91-102. PubMed ID: 26311249 [TBL] [Abstract][Full Text] [Related]
5. NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas. Cho HY; Wang W; Jhaveri N; Lee DJ; Sharma N; Dubeau L; Schönthal AH; Hofman FM; Chen TC Mol Cancer Ther; 2014 Aug; 13(8):2004-17. PubMed ID: 24994771 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma. Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370 [TBL] [Abstract][Full Text] [Related]
7. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952 [TBL] [Abstract][Full Text] [Related]
8. O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies. Sasai K; Akagi T; Aoyanagi E; Tabu K; Kaneko S; Tanaka S Mol Cancer; 2007 Jun; 6():36. PubMed ID: 17547775 [TBL] [Abstract][Full Text] [Related]
9. Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells. Happold C; Roth P; Wick W; Schmidt N; Florea AM; Silginer M; Reifenberger G; Weller M J Neurochem; 2012 Jul; 122(2):444-55. PubMed ID: 22564186 [TBL] [Abstract][Full Text] [Related]
10. MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis. Sato A; Sunayama J; Matsuda K; Seino S; Suzuki K; Watanabe E; Tachibana K; Tomiyama A; Kayama T; Kitanaka C Stem Cells; 2011 Dec; 29(12):1942-51. PubMed ID: 21957016 [TBL] [Abstract][Full Text] [Related]
11. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival. Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808 [TBL] [Abstract][Full Text] [Related]
12. Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation. Nguyen SA; Stechishin OD; Luchman HA; Lun XQ; Senger DL; Robbins SM; Cairncross JG; Weiss S Clin Cancer Res; 2014 Sep; 20(18):4894-903. PubMed ID: 25078279 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway. Huang H; Lin H; Zhang X; Li J Oncol Rep; 2012 Jun; 27(6):2050-6. PubMed ID: 22426504 [TBL] [Abstract][Full Text] [Related]
14. A novel approach to overcome temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy. Jiang G; Wei ZP; Pei DS; Xin Y; Liu YQ; Zheng JN Biochem Biophys Res Commun; 2011 Mar; 406(3):311-4. PubMed ID: 21329652 [TBL] [Abstract][Full Text] [Related]
15. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856 [TBL] [Abstract][Full Text] [Related]
16. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression. Okada M; Sato A; Shibuya K; Watanabe E; Seino S; Suzuki S; Seino M; Narita Y; Shibui S; Kayama T; Kitanaka C Int J Oncol; 2014 Feb; 44(2):591-9. PubMed ID: 24316756 [TBL] [Abstract][Full Text] [Related]
17. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281 [TBL] [Abstract][Full Text] [Related]
18. The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Voss V; Senft C; Lang V; Ronellenfitsch MW; Steinbach JP; Seifert V; Kögel D Mol Cancer Res; 2010 Jul; 8(7):1002-16. PubMed ID: 20587533 [TBL] [Abstract][Full Text] [Related]
19. The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines. Elhag R; Mazzio EA; Soliman KF Anticancer Res; 2015 Mar; 35(3):1263-9. PubMed ID: 25750273 [TBL] [Abstract][Full Text] [Related]
20. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation. Schiff D Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]